Applied Evidence

Medication-assisted recovery for opioid use disorder: A guide

Author and Disclosure Information

 

References

Second, because naltrexone does not address withdrawal symptoms, supportive therapies should be incorporated into the treatment plan, including:

  • clonidine for hyperadrenergic symptoms (anxiety, diaphoresis, hypertension)
  • nonopioid analgesics for pain
  • antiemetics, such as ondansetron and metoclopramide, for nausea or vomiting
  • loperamide for diarrhea
  • diphenhydramine for insomnia.

Third, patients taking naltrexone have a diminished response to opioids. This complicates pain management in the event of an emergent surgical procedure.

Last, when naltrexone wears off, patients are effectively opioid-naïve, which increases the risk for overdose in those who stop therapy abruptly.29 The increased risk for overdose should be communicated to all patients with OUD who are being treated with naltrexone.

This nonopioid option is appealing to policymakers and is often prioritized in the criminal justice system; however, the decreased efficacy of naltrexone (compared to methadone and buprenorphine), potential for overdose, and challenges in initiating treatment are concerning and limit the drug’s use in many real-world settings.

Because naltrexone is not a controlled substance, regulations regarding maintaining inventory and distribution are more flexible.

Continue to: Overall, the cost-effectiveness...

Pages

Recommended Reading

New guidelines for cannabis in chronic pain management released
MDedge Family Medicine
New insight into the growing problem of gaming disorder
MDedge Family Medicine
Integrating addiction medicine with primary care cost effective: Study
MDedge Family Medicine
Should you recommend e-cigs to help patients quit smoking?
MDedge Family Medicine
What will vaping lead to? Emerging research shows damage, and addiction
MDedge Family Medicine
You’ve quit smoking with vaping. Now what?
MDedge Family Medicine
Why is buprenorphine use flatlining?
MDedge Family Medicine
Survey reveals room for improvement in teen substance use screening
MDedge Family Medicine
Young men at highest schizophrenia risk from cannabis abuse
MDedge Family Medicine
Thoughts on the CDC update on opioid prescribing guidelines
MDedge Family Medicine